Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

379 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of solid tumor mutation profiles in liquid biopsy.
Balaji SA, Shanmugam A, Chougule A, Sridharan S, Prabhash K, Arya A, Chaubey A, Hariharan A, Kolekar P, Sen M, Ravichandran A, Katragadda S, Sankaran S, Bhargava S, Kulkarni P, Rao S, Sunkavalli C, Banavali S, Joshi A, Noronha V, Dutt A, Bahadur U, Hariharan R, Veeramachaneni V, Gupta V. Balaji SA, et al. Among authors: dutt a. Cancer Med. 2018 Nov;7(11):5439-5447. doi: 10.1002/cam4.1791. Epub 2018 Sep 27. Cancer Med. 2018. PMID: 30264478 Free PMC article.
Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.
Chougule A, Prabhash K, Noronha V, Joshi A, Thavamani A, Chandrani P, Upadhyay P, Utture S, Desai S, Jambhekar N, Dutt A. Chougule A, et al. Among authors: dutt a. PLoS One. 2013 Oct 4;8(10):e76164. doi: 10.1371/journal.pone.0076164. eCollection 2013. PLoS One. 2013. PMID: 24124538 Free PMC article.
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer.
Choughule A, Sharma R, Trivedi V, Thavamani A, Noronha V, Joshi A, Desai S, Chandrani P, Sundaram P, Utture S, Jambhekar N, Gupta S, Aich J, Prabhash K, Dutt A. Choughule A, et al. Among authors: dutt a. Br J Cancer. 2014 Nov 25;111(11):2203-4. doi: 10.1038/bjc.2014.401. Epub 2014 Aug 12. Br J Cancer. 2014. PMID: 25117816 Free PMC article. No abstract available.
Drug-sensitive FGFR3 mutations in lung adenocarcinoma.
Chandrani P, Prabhash K, Prasad R, Sethunath V, Ranjan M, Iyer P, Aich J, Dhamne H, Iyer DN, Upadhyay P, Mohanty B, Chandna P, Kumar R, Joshi A, Noronha V, Patil V, Ramaswamy A, Karpe A, Thorat R, Chaudhari P, Ingle A, Choughule A, Dutt A. Chandrani P, et al. Among authors: dutt a. Ann Oncol. 2017 Mar 1;28(3):597-603. doi: 10.1093/annonc/mdw636. Ann Oncol. 2017. PMID: 27998968 Free PMC article.
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, Dharavath B, Thorat R, Salunkhe S, Sahoo B, Chandrani P, Kore H, Mohanty B, Chaudhari V, Choughule A, Kawle D, Chaudhari P, Ingle A, Banavali S, Gera P, Ramadwar MR, Prabhash K, Barreto SG, Dutt S, Dutt A. Iyer P, et al. Among authors: dutt a, dutt s. Int J Cancer. 2019 Apr 15;144(8):2008-2019. doi: 10.1002/ijc.31916. Epub 2018 Dec 8. Int J Cancer. 2019. PMID: 30304546 Free PMC article.
379 results